For the reason that those who have the APOE e4 gene variant seem to have a higher danger of serious problems, the FDA suggests being tested for the gene variant before starting treatment with lecanemab or donanemab. Following staying diagnosed with dementia, You will need to contemplate many details to https://nigelr742pzi1.wikicorrespondence.com/user